Skip to main content

Market Overview

Seres Therapeutics (NASDAQ: MCRB)

20.16 -0.42 (-2.04%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/05/21Chardan CapitalUpgradesBuy30.0
12/23/20JMP SecuritiesInitiates Coverage OnMarket Perform
9/21/20Canaccord GenuityMaintainsBuy42.0
9/18/20Chardan CapitalDowngradesNeutral27.5
8/18/20Piper SandlerInitiates Coverage OnOverweight40.0
8/11/20HC Wainwright & Co.MaintainsBuy41.0
8/11/20JefferiesUpgradesBuy29.0
8/11/20Chardan CapitalMaintainsBuy32.5
3/31/20OppenheimerMaintainsOutperform7.0
4/30/19JefferiesInitiates Coverage OnHold7.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter